Abstract

Objective To explore the protective mechanism and effect of the resveratrol (Res) for liver injury of obstructive jaundice.Methods The rats were divided randomly into three groups:the sham group receiving laparotomy without bile duct ligation (BDL),the BDL group and the BDL + Res group with the Res given following BDL.The expression of the silent information regulator 1 (SIRT1) and nuclear factor-κBp56 (NF-κB) proteins were analyzed by western blotting but immunocytochemical assay was performed to examine peroxisome proliferator activated receptor-alpha (PPARα) protein.Real-time polymerase chain reaction (PCR) was performed to determine the mRNA expression of SIRT1 and PPARα.Cell apoptosis was examined by terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) staining.Results After the BDL,the cholestasis model was established.Compared B group to A group,the alanine transaminase (ALT) was higher and the mRNA and proteins expression of the SIRT1 and the PPARα was lower,but the NF-κB protein and the rate of cell apoptosis was higher (P < 0.05).Compared B group to C group,the ALT was higher and the mRNA and proteins expression of the SIRT1 and the PPARα was lower,but the NF-κB protein and the rate of cell apoptosis was significantly higher (P < 0.05).Conclusion This study demonstrates that the Res could alleviate liver damage and that the Res plays a beneficial role to resist inflammation and apoptosis by activating the SIRT1 which probably inhibits the expression of NF-κB protein in cholestatic liver injury.The Res also shows antioxidant effect by promoting the expression of PPARα. Key words: Resveratrol; Cholestasis; Silent information regulator 1 ; Peroxisome proliferator activated receptor-alpha; Nuclear factor-κBp56

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call